pteridines has been researched along with Cancer of Prostate in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Expression of this receptor is lost as prostate cancer progresses and is minimal in established prostate cancer cell lines." | 1.43 | Increased expression and activity of p75NTR are crucial events in azacitidine-induced cell death in prostate cancer. ( Biordi, L; Colapietro, A; Festuccia, C; Ficorella, C; Gravina, GL; Jitariuc, A; Mancini, A; Marampon, F; Sanità, P; Scarsella, L, 2016) |
| "SD-208 also blocked prostate cancer cell survival and invasion, and arrested cells in the G2/M phase of the cell cycle." | 1.42 | SD-208, a novel protein kinase D inhibitor, blocks prostate cancer cell proliferation and tumor growth in vivo by inducing G2/M cell cycle arrest. ( Carder, EJ; Deng, F; Farber, E; Salamoun, JM; Tandon, M; Tang, H; Wang, QJ; Wipf, P; Xu, S, 2015) |
| "TGF-β upregulates in prostate cancer cells a set of genes associated with cancer aggressiveness and bone metastases, and the most upregulated gene was PMEPA1." | 1.42 | The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone. ( Chirgwin, JM; Clines, GA; Fournier, PG; Guise, TA; Jiang, G; Juárez, P; Kim, HS; Liu, Y; Mohammad, KS; Niewolna, M; Peng, XH; Walton, HW; Wells, CD, 2015) |
| " Therefore, we studied the effect of polo-like kinase 1 (Plk1) inhibitors on prostate cancer cells as a single agent and in combination with histone deacetylase (HDAC) inhibitors valproic acid and vorinostat." | 1.39 | Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors. ( Carducci, MA; Gonzalez, M; Hammers, H; Kachhap, SK; Kaelber, NS; Kim, E; Kortenhorst, MS; Mendonca, J; van Diest, PJ; Wissing, MD, 2013) |
| "In the group of patients with renal cell carcinoma we could not find any correlation between tumor stage and neopterin excretion." | 1.27 | The value of urinary neopterin as an immunological parameter in patients with malignant tumors of the genitourinary tract. ( Aulitzky, W; Frick, J; Fuchs, D; Hausen, A; Joos, H; Reibnegger, G; Wachter, H, 1985) |
| "The patients with renal cell carcinoma did not demonstrate any definite correlation between tumor stage and urinary neopterin excretion." | 1.27 | Significance of urinary neopterin in patients with malignant tumors of the genitourinary tract. ( Aulitzky, W; Frick, J; Fuchs, D; Hausen, A; Reibnegger, G; Wachter, H, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gheghiani, L | 1 |
| Shang, S | 1 |
| Fu, Z | 1 |
| Wissing, MD | 1 |
| Mendonca, J | 1 |
| Kortenhorst, MS | 1 |
| Kaelber, NS | 1 |
| Gonzalez, M | 1 |
| Kim, E | 1 |
| Hammers, H | 1 |
| van Diest, PJ | 1 |
| Carducci, MA | 1 |
| Kachhap, SK | 1 |
| Yang, F | 1 |
| Chen, Y | 1 |
| Shen, T | 1 |
| Guo, D | 1 |
| Dakhova, O | 1 |
| Ittmann, MM | 1 |
| Creighton, CJ | 1 |
| Zhang, Y | 1 |
| Dang, TD | 1 |
| Rowley, DR | 1 |
| Shao, C | 1 |
| Ahmad, N | 1 |
| Hodges, K | 1 |
| Kuang, S | 1 |
| Ratliff, T | 1 |
| Liu, X | 1 |
| Tandon, M | 1 |
| Salamoun, JM | 1 |
| Carder, EJ | 1 |
| Farber, E | 1 |
| Xu, S | 1 |
| Deng, F | 1 |
| Tang, H | 1 |
| Wipf, P | 1 |
| Wang, QJ | 1 |
| Fournier, PG | 1 |
| Juárez, P | 1 |
| Jiang, G | 1 |
| Clines, GA | 1 |
| Niewolna, M | 1 |
| Kim, HS | 1 |
| Walton, HW | 1 |
| Peng, XH | 1 |
| Liu, Y | 1 |
| Mohammad, KS | 1 |
| Wells, CD | 1 |
| Chirgwin, JM | 1 |
| Guise, TA | 1 |
| Gravina, GL | 1 |
| Marampon, F | 1 |
| Sanità, P | 1 |
| Mancini, A | 1 |
| Colapietro, A | 1 |
| Scarsella, L | 1 |
| Jitariuc, A | 1 |
| Biordi, L | 1 |
| Ficorella, C | 1 |
| Festuccia, C | 1 |
| Frick, J | 2 |
| Aulitzky, W | 2 |
| Fuchs, D | 2 |
| Hausen, A | 2 |
| Joos, H | 1 |
| Reibnegger, G | 2 |
| Wachter, H | 2 |
| Lewenhaupt, A | 1 |
| Ekman, P | 1 |
| Eneroth, P | 1 |
| Eriksson, A | 1 |
| Nordström, L | 1 |
10 other studies available for pteridines and Cancer of Prostate
| Article | Year |
|---|---|
Targeting the PLK1-FOXO1 pathway as a novel therapeutic approach for treating advanced prostate cancer.
Topics: Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Cell Nucleus; Cell Survival; Drug Synergism; Forkh | 2020 |
Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors.
Topics: Antineoplastic Agents; Cell Cycle Proteins; Cell Line, Tumor; Drug Therapy, Combination; Histone Dea | 2013 |
Stromal TGF-β signaling induces AR activation in prostate cancer.
Topics: Androgens; Apoptosis; Benzamides; Blotting, Western; Bone Morphogenetic Protein 6; Cell Proliferatio | 2014 |
Inhibition of polo-like kinase 1 (Plk1) enhances the antineoplastic activity of metformin in prostate cancer.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferatio | 2015 |
SD-208, a novel protein kinase D inhibitor, blocks prostate cancer cell proliferation and tumor growth in vivo by inducing G2/M cell cycle arrest.
Topics: Animals; Cell Proliferation; G2 Phase Cell Cycle Checkpoints; Humans; M Phase Cell Cycle Checkpoints | 2015 |
The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone.
Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Disease Models, Animal; | 2015 |
Increased expression and activity of p75NTR are crucial events in azacitidine-induced cell death in prostate cancer.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Caspase 3; Caspase 9; Cell Cycle; | 2016 |
The value of urinary neopterin as an immunological parameter in patients with malignant tumors of the genitourinary tract.
Topics: Adolescent; Adult; Aged; Biopterins; Carcinoma, Renal Cell; Chromatography, High Pressure Liquid; Dy | 1985 |
Serum levels of prostatic acid phosphatase (PAP), tissue polypeptide antigen (TPA), CA-50, neopterine and of osteocalcin in patients with prostatic carcinoma.
Topics: Acid Phosphatase; Aged; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Biopterins; Ca | 1985 |
Significance of urinary neopterin in patients with malignant tumors of the genitourinary tract.
Topics: Adolescent; Adult; Aged; Biopterins; Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Male; | 1985 |